Australia’s Evolution Healthcare pays premium to buy stake in rival Acurity Health

Evolution Healthcare, the Australian private equity healthcare company which owns Boulcott Hospital in Lower Hutt, is buying shares in Acurity Health which owns rival Wakefield Hospital.

Shares in private hospital group Acurity Health jumped 36 percent to an 11-month high as about 3.8 percent of the stock changed hands at $5.50.

Evolution Healthcare "is obviously trying to buy a large stake in Acurity Health," said Bryon Burke, head of equities at Craigs Investment Partners. Burke said Evolution was paying a premium to get volume although he didn't know how big a stake was being sought.

Evolution also owns Shellharbour Private Hospital, South Coast Private and Canberra Private Hospital, according to the company's website. Managing director Ben Thynne wasn't immediately available for comment.

BusinessDesk.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

NZ dollar falls ahead of inflation data
F&P Healthcare shares hit record on improved guidance
Bounce in international guest nights some reprieve for slowing tourism sector
$4m penalty for Auckland money shop under AML regime
High-emission oil producers at risk from investor action
NZ Rugby gets skin in media game in new Sky broadcasting deal
14th October 2019 Morning Report
US earnings season starts amid glimmers of hope on trade, Brexit
Class action suit against CBL Corp about to launch
NZ dollar benefits from possible US-China trade deal